Skip to main content
Perspective Therapeutics, Inc. (CATX)
NYSEAMERICAN: CATX · Real-Time Price · USD
6.17
-0.61 (-9.00%)
At close: Nov 20, 2024, 4:00 PM
6.30
+0.13 (2.11%)
After-hours: Nov 20, 2024, 7:47 PM EST

Perspective Therapeutics Revenue

Perspective Therapeutics had revenue of $369.00K in the quarter ending September 30, 2024, with 33.70% growth. This brings the company's revenue in the last twelve months to $1.56M, down -351.13% year-over-year. In the year 2023, Perspective Therapeutics had annual revenue of $1.43M, down -73.52%.

Revenue (ttm)
$1.56M
Revenue Growth
-351.13%
P/S Ratio
212.97
Revenue / Employee
$13,084
Employees
119
Market Cap
417.02M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20231.43M-3.98M-73.52%
Dec 31, 20225.42M--
Jun 30, 2022---
Jun 30, 202110.05M373.00K3.85%
Jun 30, 20209.68M2.37M32.35%
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro
Jun 30, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Emergent BioSolutions 1.13B
GRAIL 117.67M
Y-mAbs Therapeutics 84.55M
Theravance Biopharma 63.19M
Cartesian Therapeutics 47.94M
MeiraGTx Holdings 13.93M
Taysha Gene Therapies 9.92M
Revenue Rankings

CATX News

More News